| Literature DB >> 32148706 |
Alina Engelman1, Ben Case2, Lisa Meeks2, Michael D Fetters3.
Abstract
Healthcare guidelines play a prominent role in the day-to-day practice of primary care providers, and health policy research leads to the formation of these guidelines. Health policy research is the multidisciplinary approach to public policy explaining the interaction between health institutions, special interests and theoretical constructs. In this article, we demonstrate how primary care providers can conduct high-impact health policy research using Eugene Bardach's eightfold policy analysis framework in a primary care context. In a medical case, a woman with a history of total hysterectomy had scheduled a visit for a Papanicolaou (Pap) smear screening test as part of a well-woman health check-up with a family medicine resident. Conflicting recommendations on Pap smear screening after total hysterectomy sparked an investigation using the US Preventive Services Task Force criteria for conducting a health policy analysis. We illustrate broadly how clinical care dilemmas can be examined by using Bardach's broadly applicable health policy framework in order to inform meaningful policy change. Bardach's framework includes (1) defining the problem, (2) assembling evidence, (3) constructing alternatives, (4) selecting criteria, (5) projecting outcomes, (6) confronting trade-offs, (7) decision-making and (8) sharing the results of the process. The policy analysis demonstrated insufficient evidence to recommend Pap test screening after hysterectomy and the findings contributed to national recommendations. By following Bardach's steps, primary care researchers have a feasible and powerful tool for conducting meaningful health policy research and analysis that can influence clinical practice. © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: Cervical Cancer; family medicine; health policy research; limited resources; primary health care
Year: 2019 PMID: 32148706 PMCID: PMC6910741 DOI: 10.1136/fmch-2018-000076
Source DB: PubMed Journal: Fam Med Community Health ISSN: 2305-6983
Health policy analysis studies that have been led by primary care and public health researchers
| Topic | Recommendation | Authors |
| Utility of Papanicoloau (Pap) screening after total hysterectomy for benign disease. | There is insufficient evidence to recommend Pap screening after total hysterectomy for benign disease. | Fetters, |
| Cost-effectiveness of Pap smear screening for vaginal cancer after total hysterectomy for benign disease. | As significant costs were associated with any screening strategy without demonstrable gain in life expectancy, the authors concluded Pap smear screening after total hysterectomy for benign disease was not cost-effective. | Fetters, |
| US medical school compliance with the Americans with Disabilities Act (ADA). | Most U.S. medical school technical standards do not support provision of reasonable accommodations for students with disabilities as intended by the Americans with Disabilities Act (ADA). | Zazove |
| Support for medical professionals with disabilities. | A lack of uniform practice contributes to disparate access to medical education for learners with disabilities. | Meeks and Jain |
Figure 1Figure defining a healthcare policy problem prompted by the question of whether women who have undergone hysterectomy should undergo Papanicolaou screening for cancer.
Example of health policy analysis to inform improvements in guidelines for Pap smears after total hysterectomy for benign disease through Bardach’s steps 1–8
| Step | Example from Fetters |
| 1. Define the problem. | Lack of evidence and controversial recommendations regarding Pap smear screening after total hysterectomy for benign disease. |
| 2. Assemble evidence. |
Medline review of medical literature, including case studies, using terms: hysterectomy and vaginal smears or vaginal smears and vaginal neoplasm. Review major textbooks of gynaecology. Review recommendations from major organisations with known background in screening, cancer and women’s health issues. |
| 3. Construct alternatives. | Describe assumptions and positions justifying each policy under consideration, including existing cervical cancer guidelines of Pap smears after total hysterectomy for benign disease or cessation of the practice. |
| 4. Select the criteria. | USPSTF criteria to measure and evaluate the practicality and sustainability of each alternative. Included consideration of the survival rate, and cost-effectiveness of the diagnosis and treatment. |
| 5. Project the outcomes. | Quantify the magnitude of the impact of each alternative, including the cost of false positives due to low prevalence, as well as the number of missed cases of vaginal dysplasia or carcinoma due to lack of screening. |
| 6. Confronting the trade-offs. | Weigh the relative benefit and importance of each criterion, such as the cost savings of eliminating screenings against the relative risks of missed diagnoses for each alternative. |
| 7. Decision-making. | Insufficient evidence for Pap smears after total hysterectomy for benign disease, although patients who undergo subtotal hysterectomy should still receive regular Pap smears due to retention of the cervix. |
| 8. Sharing the results of the process. | Presentation to USPSTF for consideration and subsequent revision of the USPSTF guidelines. |
Pap smear, Papanicolaou smear; USPSTF, US Preventive Services Task Force.